Bioresorbable polystatin fourth-generation stents

Coronary Artery Disease

Volumn 24, Issue 6, 2013, Pages 516-521

  Kaesemeyer, Wayne H ^a   Sprankle, Kelly G ^a   Kremsky, Jon N ^b   Lau, Wing ^d   Helmus, Michael N ^c   Ghatnekar, Gautam S ^a  

^a Regranion LLC   (United States)

^b Prime Organics Inc   (United States)

^c 3D Biotek LLC ^*

^d 3D Biotek LLC   (United States)

Author keywords

bioresorbable stents; bleeding; dual antiplatelet therapy; polystatins; stent thrombosis

Indexed keywords

MEVINOLIN; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIDE; SCANDIUM;

ARTICLE; CATALYST; DRUG TARGETING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERIZATION; PRIORITY JOURNAL; RESTENOSIS; STENT; STENT THROMBOSIS;

EID: 84881548973     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283643a4a     Document Type: Article

References (17)

1. Mehran R, Pocock S, Nikolsky E, Dangas GD, Clayton T, Claessen BE, et al. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials. JACC Cardiovasc Interv 2011; 4: 654-664.
2. Long C, Cook LG, Hamilton SL, Wu GY, Mitchell BM. FK506 binding protein 12/12.6 depletion increases endothelial nitric oxide synthase threonine 495 phosphorylation and blood pressure. Hypertension 2007; 49:569-576.
3. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007; 115:1051-1058.
4. Pendyala LK, Xinhua Y, Li J, Chen JP, Chronos N, Hou D. The first-generation drug eluting stents and endothelial dysfunction. JACC Cardiovasc Interv 2009; 2:1169-1177.
5. Alfonso F, Fernandez C. Second-generation drug-eluting stents moving the field forward. J Am Coll Cardiol 2011; 58:26-29.
6. Valente S, Lazzeri C, Chiostri M, Osmanagaj L, Giglioli C, Gensini GF. STEMI patients-the more you bleed, the more you die: a comparison between classifications. Clin Cardiol 2011; 34:90-96.
7. Capodanno D, Dipasqua F, Tamburino C. Novel drug-eluting stents in the treatment of de novo coronary lesions. Vasc Health Risk Manag 2011; 7:103-118.
8. Onuma Y, Serruys PW. Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization? Circulation 2011; 123:779-797.
9. Nomura N, Taira A, Nakase A, Tomioka T, Okada M. Ring-opening polymerization of lactones by rare-earth metal triflates and by their reusable system in ionic liquids. Tetrahedron 2007; 63:8478-8484.
10. Moller M, Nederberg F, Lim L, Kange R, Hawker CJ, Hedrick JL, et al. Stannous(II) trifluoromethane sulfonate: a versatile catalyst for the controlled ring-opening polymerization of lactides: formation of stereoregular surfaces from polylactide "brushes". J Polym Sci A 2001; 39:3529-3538.
11. Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol 1999; 33:234-241.
12. Datar R, Kaesemeyer WH, Chandra S, Fulton DJ, Caldwell RW. Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx. Br J Pharmacol 2010; 160:1765-1772.
13. Kaesemeyer W. Statin drug eluting stent (DES) for early stent thrombosis. Atherosclerosis 2009; 207:343.
14. Balakrishnan B, Dooley JF, Kopia G, Edelman ER. Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release 2007; 123:100-108.
15. Kolachalamaa VB, Tzafriria AR, Arifinb DY, Edelmana ER. Luminal flow patterns dictate arterial drug deposition in stent based delivery. J Control Release 2009; 133:24-30.
16. Patel N, Banning AP. Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention? Heart 2013 (in press) [Epub ahead of print].
17. Pektok E, Nottelet B, Tille JC, Gurny R, Kalangos A, Moeller M, Walpoth BH. Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008; 118:2563-2570.